State Of Wyoming Sangamo Therapeutics, Inc Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.42 - $1.38 $32,615 - $107,163	-77,655 Reduced 50.76%	75,319 $50,000
Q4 2023 Feb 14, 2024	BUY	$0.3 - $0.63 $18,184 - $38,186	60,614 Added 65.63%	152,974 $82,000
Q3 2023 Nov 14, 2023	BUY	$0.58 - $1.47 $53,568 - $135,769	92,360 New	92,360 $55,000
Q2 2021 Feb 11, 2022	BUY	$10.17 - $12.64 $20 - $25	2 Added 5.88%	36 $0
Q1 2021 Feb 08, 2022	BUY	$10.88 - $17.05 $369 - $579	34 New	34 $0

113

57.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $182M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.